SMIM22 and non-small cell lung carcinoma: Given that SMIM22 is targeted by lncRNA NORAD in EVs in vitro, it is plausible to speculate that lncRNA NORAD in EVs influences the expression of SMIM22/GALE through the miR-520g-3p axis, thereby accelerating glycolysis in NSCLC cells.